PFIZER vs PGHL: Stock Comparison

PFIZER vs PROCTER & GAMBLE HEALTH LUpdated 4 Sept 26, 4:08 PM ISTNSE & company filings

PFIZER is the larger company by market capitalisation. PFIZER shows a higher net margin, while PROCTER & GAMBLE HEALTH L shows a lower P/E, a higher ROE and a higher dividend yield. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

PFIZER leads 4; PGHL leads 8 of 13

Not a rating

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

PFIZERPGHL

Valuation lens

What price are you paying?

Market CapContext only
₹21,044 Cr
₹9,379 Cr
P/E RatioPGHL has the lower reading
28.9x
26.43x
P/B RatioPFIZER has the lower reading
5.05x
17.98x
EPSPGHL has the higher reading
₹44.7
₹57.92
Book ValueContext only
₹918.71
₹316.01
Dividend YieldPGHL has the higher reading
1.6%
3.45%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
PFIZER is the larger company
₹21,044 Cr vs ₹9,379 Cr
P/E Ratio
PGHL has a lower P/E
26.43x vs 28.9x
P/B Ratio
PFIZER has a lower P/B
5.05x vs 17.98x
EPS
PGHL has higher earnings per share
₹57.92 vs ₹44.7
Dividend Yield
PGHL has a higher dividend yield
3.45% vs 1.6%
Revenue Growth (TTM YoY)
PGHL has faster revenue growth
19.1% vs 6.3%
EPS Growth (TTM YoY)
PGHL has faster EPS growth
54.6% vs -39.6%
Qtr Sales Growth
PFIZER has stronger quarterly sales growth
-74.08% vs -74.17%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricPFIZERPGHL
SectorHealthcareHealthcare
IndustryPharmaceuticalsPharmaceuticals

Price

MetricPFIZERPGHL
Live Price₹4,609.7₹5,660
Day Change-0.73%-1.69%
Volume32,7397,255
52-Week High₹5,578.5₹6,975
52-Week Low₹4,360.1₹4,707
Distance from 52W High-17.37%-18.85%

Valuation

MetricPFIZERPGHL
Market Cap₹21,044 Cr₹9,379 Cr
P/E Ratio28.9x26.43x
P/B Ratio5.05x17.98x
EPS₹44.7₹57.92
Book Value₹918.71₹316.01
Dividend Yield1.6%3.45%

Growth

MetricPFIZERPGHL
Revenue Growth (TTM YoY)6.3%19.1%
EPS Growth (TTM YoY)-39.6%54.6%
Qtr Sales Growth-74.08%-74.17%
Qtr Profit Growth-71.7%-70.59%

Profitability & Leverage

MetricPFIZERPGHL
ROE17.19%62.32%
ROCE17.78%92.1%
Net Margin28.67%23.22%
Operating Margin39.1%31.99%
Debt to Equity0x0x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricPFIZERPGHL
Promoter Holding63.92%0%
FII Holding1.65% 1.16 pp6.33% 0.13 pp
DII Holding17.8% 0.91 pp12.44% 1.23 pp
Public Holding16.63% 0.26 pp29.42% 1.11 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: PFIZER and PROCTER & GAMBLE HEALTH L.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.